Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries

Daniel Trifiletti, Nirav Patel, Cheng Chia Lee, Andrew M. Romano, Jason P. Sheehan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Brain metastases from gastrointestinal (GI) primary malignancies are generally less common than those arising from other primary locations. Our purpose was to analyze the efficacy of stereotactic radiosurgery (SRS) in the treatment of patients with brain metastases from GI malignancies in the modern radiosurgical and systemic therapy era. A review of patients treated with SRS to brain metastases from GI primaries treated from 1996 to 2015 at our institution was conducted. Clinical, therapeutic, dosimetric and radiographic characteristics were collected and analyzed for an association with brain tumor local control (LC) and overall survival (OS) following SRS using univariate and multivariate (MVA) analyses. 261 brain metastases were identified from 86 patients meeting inclusion criteria. The most common primary location was rectum (n = 36). LC was 94.1 % at last follow up and margin dose ≥20 Gy was associated with improved LC on MVA (p = 0.038). Median OS was 6.2 months and was improved with higher performance score and luminal primary location on MVA (p = 0.002 and 0.015, respectively). Tumor histology, whole brain irradiation, targeted therapies, and antineoplastic therapies were not associated with improved LC or OS on MVA. SRS provides favorable LC of brain metastases of GI origin, and margin doses of at least 20 Gy should be considered when clinically appropriate. Compared to non-luminal primaries, patients with brain metastases from a luminal primary demonstrate improved OS.

Original languageEnglish (US)
Pages (from-to)439-446
Number of pages8
JournalJournal of neuro-oncology
Volume124
Issue number3
DOIs
StatePublished - Sep 30 2015
Externally publishedYes

Fingerprint

Radiosurgery
Neoplasm Metastasis
Brain
Survival
Therapeutics
Neoplasms
Rectum
Brain Neoplasms
Antineoplastic Agents
Histology
Multivariate Analysis

Keywords

  • Brain
  • Gamma Knife
  • Gastrointestinal
  • Luminal
  • Metastasis
  • Radiosurgery

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries. / Trifiletti, Daniel; Patel, Nirav; Lee, Cheng Chia; Romano, Andrew M.; Sheehan, Jason P.

In: Journal of neuro-oncology, Vol. 124, No. 3, 30.09.2015, p. 439-446.

Research output: Contribution to journalArticle

Trifiletti, Daniel ; Patel, Nirav ; Lee, Cheng Chia ; Romano, Andrew M. ; Sheehan, Jason P. / Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries. In: Journal of neuro-oncology. 2015 ; Vol. 124, No. 3. pp. 439-446.
@article{95a67cbf98e142e8861fbb85dd759829,
title = "Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries",
abstract = "Brain metastases from gastrointestinal (GI) primary malignancies are generally less common than those arising from other primary locations. Our purpose was to analyze the efficacy of stereotactic radiosurgery (SRS) in the treatment of patients with brain metastases from GI malignancies in the modern radiosurgical and systemic therapy era. A review of patients treated with SRS to brain metastases from GI primaries treated from 1996 to 2015 at our institution was conducted. Clinical, therapeutic, dosimetric and radiographic characteristics were collected and analyzed for an association with brain tumor local control (LC) and overall survival (OS) following SRS using univariate and multivariate (MVA) analyses. 261 brain metastases were identified from 86 patients meeting inclusion criteria. The most common primary location was rectum (n = 36). LC was 94.1 {\%} at last follow up and margin dose ≥20 Gy was associated with improved LC on MVA (p = 0.038). Median OS was 6.2 months and was improved with higher performance score and luminal primary location on MVA (p = 0.002 and 0.015, respectively). Tumor histology, whole brain irradiation, targeted therapies, and antineoplastic therapies were not associated with improved LC or OS on MVA. SRS provides favorable LC of brain metastases of GI origin, and margin doses of at least 20 Gy should be considered when clinically appropriate. Compared to non-luminal primaries, patients with brain metastases from a luminal primary demonstrate improved OS.",
keywords = "Brain, Gamma Knife, Gastrointestinal, Luminal, Metastasis, Radiosurgery",
author = "Daniel Trifiletti and Nirav Patel and Lee, {Cheng Chia} and Romano, {Andrew M.} and Sheehan, {Jason P.}",
year = "2015",
month = "9",
day = "30",
doi = "10.1007/s11060-015-1857-3",
language = "English (US)",
volume = "124",
pages = "439--446",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries

AU - Trifiletti, Daniel

AU - Patel, Nirav

AU - Lee, Cheng Chia

AU - Romano, Andrew M.

AU - Sheehan, Jason P.

PY - 2015/9/30

Y1 - 2015/9/30

N2 - Brain metastases from gastrointestinal (GI) primary malignancies are generally less common than those arising from other primary locations. Our purpose was to analyze the efficacy of stereotactic radiosurgery (SRS) in the treatment of patients with brain metastases from GI malignancies in the modern radiosurgical and systemic therapy era. A review of patients treated with SRS to brain metastases from GI primaries treated from 1996 to 2015 at our institution was conducted. Clinical, therapeutic, dosimetric and radiographic characteristics were collected and analyzed for an association with brain tumor local control (LC) and overall survival (OS) following SRS using univariate and multivariate (MVA) analyses. 261 brain metastases were identified from 86 patients meeting inclusion criteria. The most common primary location was rectum (n = 36). LC was 94.1 % at last follow up and margin dose ≥20 Gy was associated with improved LC on MVA (p = 0.038). Median OS was 6.2 months and was improved with higher performance score and luminal primary location on MVA (p = 0.002 and 0.015, respectively). Tumor histology, whole brain irradiation, targeted therapies, and antineoplastic therapies were not associated with improved LC or OS on MVA. SRS provides favorable LC of brain metastases of GI origin, and margin doses of at least 20 Gy should be considered when clinically appropriate. Compared to non-luminal primaries, patients with brain metastases from a luminal primary demonstrate improved OS.

AB - Brain metastases from gastrointestinal (GI) primary malignancies are generally less common than those arising from other primary locations. Our purpose was to analyze the efficacy of stereotactic radiosurgery (SRS) in the treatment of patients with brain metastases from GI malignancies in the modern radiosurgical and systemic therapy era. A review of patients treated with SRS to brain metastases from GI primaries treated from 1996 to 2015 at our institution was conducted. Clinical, therapeutic, dosimetric and radiographic characteristics were collected and analyzed for an association with brain tumor local control (LC) and overall survival (OS) following SRS using univariate and multivariate (MVA) analyses. 261 brain metastases were identified from 86 patients meeting inclusion criteria. The most common primary location was rectum (n = 36). LC was 94.1 % at last follow up and margin dose ≥20 Gy was associated with improved LC on MVA (p = 0.038). Median OS was 6.2 months and was improved with higher performance score and luminal primary location on MVA (p = 0.002 and 0.015, respectively). Tumor histology, whole brain irradiation, targeted therapies, and antineoplastic therapies were not associated with improved LC or OS on MVA. SRS provides favorable LC of brain metastases of GI origin, and margin doses of at least 20 Gy should be considered when clinically appropriate. Compared to non-luminal primaries, patients with brain metastases from a luminal primary demonstrate improved OS.

KW - Brain

KW - Gamma Knife

KW - Gastrointestinal

KW - Luminal

KW - Metastasis

KW - Radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=84942501416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942501416&partnerID=8YFLogxK

U2 - 10.1007/s11060-015-1857-3

DO - 10.1007/s11060-015-1857-3

M3 - Article

C2 - 26186901

AN - SCOPUS:84942501416

VL - 124

SP - 439

EP - 446

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -